Table 2.
Relative risk estimates from robust Poisson regressions with 95%-confidence intervals.
| Risk factor | RR | 95%-CI | RR | 95%-CI | RR | 95%-CI |
|---|---|---|---|---|---|---|
| COVID-19 ARDS (ref: no) | ||||||
| yes | 2.02 * | (1.57–2.60) | 1.74 * | (1.35–2.24) | 1.80 * | (1.12–2.90) |
| Age (in years) | 1.02 * | (1.00–1.03) | 1.02 * | (1.00–1.03) | ||
| Sex (ref: female) | ||||||
| male | 0.92 | (0.72–1.19) | 0.87 | (0.69–1.11) | ||
| BMI (in kg/m2 ref: <35) | ||||||
| 35-< 40 | 0.81 | (0.55–1.21) | 0.86 | (0.60–1.22) | ||
| 40 + | 1.10 | (0.71–1.71) | 1.06 | (0.74–1.53) | ||
| Charlson Comorbidity Index | 1.01 | (0.96–1.06) | 1.01 | (0.96–1.06) | ||
| SOFA score | 1.08 * | (1.04–1.12) | 1.02 | (0.99–1.05) | ||
| RRT (ref: no) | ||||||
| yes | 1.49 * | (1.18–1.88) | ||||
| ECMO (ref: no) | ||||||
| yes | 1.18 | (0.91–1.53) | ||||
| Invasive ventilation (ref: no) | ||||||
| yes | 2.45 * | (1.36–4.41) | ||||
| PE (ref: no) | ||||||
| yes | 1.09 | (0.84–1.41) | ||||
| DVT (ref: no) | ||||||
| yes | 1.02 | (0.79–1.31) | ||||
| CRP maximum value (in mg/L ref: <200) | ||||||
| 200–400 | 1.34 | (0.98–1.84) | ||||
| > 400 | 1.03 | (0.69–1.53) | ||||
| PCTmax (in ng/mlref: <2) | ||||||
| > =2 | 1.62 * | (1.14–2.31) | ||||
| Leucocytes minimum value_cat (in GPt/L ref: <=3.8) | ||||||
| > 3.8 | 1.03 | (0.77–1.39) | ||||
| Leucocytes maximum value_cat (in GPt/L ref: <20) | ||||||
| > =20 | 0.98 | (0.78–1.24) | ||||
| Septic schock (ref: no) | ||||||
| yes | 1.43 * | (1.12–1.81) | ||||
| Other focus than pulmonary (ref: no) yes |
1.17 | (0.70–1.96) | ||||
| Constant | 0.29 * | (0.24–0.37) | 0.05 * | (0.02–0.12) | 0.02 * | (0.01–0.04) |
| n | 368 | 368 | 368 |
ARDS = Acute Respiratory Distress Syndrome, BMI = Body Mass Index, CRP = C - reactive protein, DVT = Deep Vein Thrombosis, ECMO = Extracorporeal Membrane Oxygenation, LAE = Intensive Care Unit, PE = Pulmonary Embolism, PCT = Procalcitonin, RRT = Renal Replacement Therapy.
RR = relative risk; CI = confidence interval; significance levels: * <5%.